Monitoring Disease Progress in Mesothelioma

Clinical Progress Tracking the progression of mesothelioma is crucial for both patient care and medical research. Physicians monitor changes in body weight, lung function (FEV1, FVC), and other physical indicators to gauge disease advancement or response to treatment. Quality of life assessments using validated tools are also a key part of the process. Physical markers can be helpful, such as tracking the size of skin lumps as an indication of treatment response.